Evercore ISI Group Upgrades Cardinal Health to Outperform, Maintains Price Target to $140
Evercore ISI Group Upgrades Cardinal Health to Outperform, Maintains Price Target to $140
Evercore ISI集團將卡地納健康評級上調至跑贏大盤,維持價格目標爲140美元
Evercore ISI Group analyst Elizabeth Anderson upgrades Cardinal Health (NYSE:CAH) from In-Line to Outperform and maintains the price target from $140 to $140.
Evercore ISI集團分析師伊麗莎白·安德森將卡地納健康(紐交所:CAH)從中性評級上調至跑贏大盤,並將目標價維持在140美元不變。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。